Class action lawsuits
Pomerantz LLP is leading an investigation into potential securities fraud allegations against Neogen Corporation, following the company's disclosure of its fourth quarter fiscal 2025 financial results. On June 4, 2025, Neogen announced that its EBITDA margin would likely be around 17%, a significant decline from the previous quarter&
Class action lawsuits
Investors who purchased Neogen Corporation securities between January 5, 2023, and June 3, 2025, are encouraged to join a class action lawsuit against the company and its officers, alleging violations of the federal securities laws. The complaint claims that Neogen made false and misleading statements about the integration of its
Class action lawsuits
Reddit, Inc. and certain of its senior executives have been hit with a lawsuit alleging violations of federal securities laws. The complaint asserts that Reddit misrepresented the impact of Google's Artificial Intelligence (AI) technology on Reddit's user growth, causing a decline in stock price. Investors who
Class action lawsuits
Apple has been hit with a lawsuit alleging that the company and its senior executives violated federal securities laws by misrepresenting the advanced AI features of its Siri digital personal assistant and delaying the release of new products to artificially inflate stock prices. The complaint asserts claims under Sections 10(
Class action lawsuits
A securities lawsuit has been filed against Hims & Hers Health, Inc. and certain of its senior executives for potential violations of federal securities laws. The lawsuit, captioned Sookdeo v. Hims & Hers Health, Inc., et al., No. 25-cv-05315, was filed in the U.S. District Court for the Northern
Class action lawsuits
Investors in Centene Corporation, a healthcare company that serves consumers in government-sponsored healthcare programs, may have legal options after the company was sued for potential securities law violations. A lawsuit was filed against Centene and its senior executives, alleging that they made false statements about the company's financial
Class action lawsuits
Purchasers of Rocket Pharmaceuticals securities between September 17, 2024, and May 26, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs due to a class action lawsuit. A lead plaintiff must be appointed by August 11, 2025, to direct the litigation. The Rosen Law Firm,
Class action lawsuits
Berger Montague PC, a nationally recognized securities litigation firm, is investigating a newly filed securities class action lawsuit against Rocket Pharmaceuticals, Inc. The suit alleges that the company misled investors regarding critical safety disclosures tied to its RP-A501 gene therapy program. Rocket Pharmaceuticals, a biotechnology company focused on developing gene
Class action lawsuits
Investors who lost money in Reddit, Inc. between October 2024 and May 2025 may be eligible for compensation. A class action lawsuit was filed against the company, alleging that executives made false statements about the impact of Google Search changes on user traffic and advertising revenues. The lawsuit claims that
Class action lawsuits
Centene Corporation, a leading healthcare enterprise, is facing a class action lawsuit alleging that the company misled investors regarding its business prospects. The lawsuit, filed on behalf of investors who purchased or acquired Centene securities between December 12, 2024 and June 30, 2025, claims that the company created a false
Class action lawsuits
Purchasers of Neogen Corporation's common stock between January 5, 2023, and June 3, 2025, may be eligible for compensation due to alleged false and misleading statements made by the company about the integration process. Rosen Law Firm, a global investor rights law firm, has filed a class action
Class action lawsuits
The Rosen Law Firm, a global investor rights law firm, reminds investors who purchased common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025, and June 23, 2025, that they may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency
